146 related articles for article (PubMed ID: 4865519)
1. Humoral factors in the pathogenesis of Graves' disease.
McKenzie JM
Physiol Rev; 1968 Jan; 48(1):252-310. PubMed ID: 4865519
[No Abstract] [Full Text] [Related]
2. Current concepts concerning the pathogenesis of the hyperthyroidism of Graves' disease.
Orth DN
J Tenn Med Assoc; 1967 Jan; 60(1):41-7. PubMed ID: 5343003
[No Abstract] [Full Text] [Related]
3. [New ideas on the regulation of thyroid function by LATS (long-acting thyroid stimulator) and their repercussion on human pathology].
Strumia E
Minerva Med; 1967 Nov; 58(90):3879-85. PubMed ID: 5630606
[No Abstract] [Full Text] [Related]
4. Does LATS cause hyperthyroidism in Graves' disease? (A review biased toward the affirmative).
McKenzie JM
Metabolism; 1972 Sep; 21(9):883-94. PubMed ID: 4115791
[No Abstract] [Full Text] [Related]
5. [Etiopathogenesis of thyrotoxicosis].
de Medeiros Neto GA
Rev Paul Med; 1967 Jan; 70(1):48-52. PubMed ID: 5631892
[No Abstract] [Full Text] [Related]
6. Mechanisms of Graves' disease and endocrine exophthalmos.
Anderson DR
Am J Ophthalmol; 1969 Jul; 68(1):46-57. PubMed ID: 4895778
[No Abstract] [Full Text] [Related]
7. [Pathogenesis of Basedow's disease].
Wuttke H
Fortschr Med; 1978 Dec; 96(46):2325-8. PubMed ID: 581489
[TBL] [Abstract][Full Text] [Related]
8. [Simultaneous determination of thyreotropic hormone and long-acting thyroid stimulator in the plasma of Basedow patients].
Földes J; Gesztesi E; Takács I
Orv Hetil; 1970 Dec; 111(52):3067-70. PubMed ID: 4099957
[No Abstract] [Full Text] [Related]
9. [New knowledge about the pathogenesis of hyperthyroidism].
Küchel O; Horký K
Cas Lek Cesk; 1969 Jul; 108(28):833-8. PubMed ID: 4978076
[No Abstract] [Full Text] [Related]
10. Pathogenesis of neonatal Graves' disease.
McKenzie JM; Zakarija M
J Endocrinol Invest; 1978 Apr; 1(2):183-9. PubMed ID: 385703
[No Abstract] [Full Text] [Related]
11. Observations against a causal relationship between the long-acting thyroid stimulator and ophthalmopathy in Graves' disease.
McKenzie JM; McCullagh EP
J Clin Endocrinol Metab; 1968 Aug; 28(8):1177-82. PubMed ID: 4175472
[No Abstract] [Full Text] [Related]
12. The eye changes of Graves' disease: overview.
Werner SC
Mayo Clin Proc; 1972 Dec; 47(12):969-74. PubMed ID: 4564711
[No Abstract] [Full Text] [Related]
13. The long-acting thyroid stimulator and thyroid disease.
Kriss JP
Adv Intern Med; 1970; 16():135-54. PubMed ID: 4247613
[No Abstract] [Full Text] [Related]
14. [The pathogenesis of hyperthyreosis].
Scazziga BR
Ther Umsch; 1972 Sep; 29(9):550-3. PubMed ID: 4678189
[No Abstract] [Full Text] [Related]
15. Familial incidence of long-acting thyroid stimulator (LATS) in Graves' disease.
Bonnyns M; Vanhaelst L
Horm Metab Res; 1972 Mar; 4(2):132. PubMed ID: 5067566
[No Abstract] [Full Text] [Related]
16. The long-acting thyroid stimulator: its role in Graves' disease.
McKenzie JM
Recent Prog Horm Res; 1967; 23():1-46. PubMed ID: 4174931
[No Abstract] [Full Text] [Related]
17. [Exophthalmic goiter and long acting thyroid stimulator].
Ochi Y; Yatsutani T; Abe S; Shiomi K
Horumon To Rinsho; 1970 Nov; 18(11):907-14. PubMed ID: 5536677
[No Abstract] [Full Text] [Related]
18. Neutralization of "long-acting thyroid stimulator" of Graves' disease by antisera to bovine pituitary thyrotropin.
WERNER SC; TIERNEY J
Proc Soc Exp Biol Med; 1961 Dec; 108():780-4. PubMed ID: 14006235
[No Abstract] [Full Text] [Related]
19. Concepts of pathogenesis of Graves' disease.
Solomon DH; Kleeman KE
Adv Intern Med; 1977; 22():273-99. PubMed ID: 402796
[No Abstract] [Full Text] [Related]
20. [Long-acting thyroid stimulator (L.A.T.S.) and its place in the physiopathogeny of Basedowian hyperthyroidism].
Guéritée N
Rev Fr Endocrinol Clin; 1968; 9(4):351-66. PubMed ID: 5755332
[No Abstract] [Full Text] [Related]
[Next] [New Search]
